查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲家禽疫苗市場預測至 2031 年 - 區域分析 - 按類型、技術、劑型、疾病、給藥途徑和最終用戶
市場調查報告書
商品編碼
1597055

歐洲家禽疫苗市場預測至 2031 年 - 區域分析 - 按類型、技術、劑型、疾病、給藥途徑和最終用戶

Europe Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User
出版日期: | 出版商: The Insight Partners | 英文 153 Pages | 訂單完成後即時交付

價格

2023年歐洲家禽疫苗市值為3.2182億美元，預計2031年將達到6.3501億美元；預計2023年至2031年複合年成長率為8.9%。

不斷成長的家禽業推動歐洲家禽疫苗市場

根據美國農業部 (USDA) 的報告，過去二十年來，家禽已成為全球消費最多的畜牧商品，特別是在發展中國家和新興市場。此外，根據美國農業部的同一份報告，預計未來 10 年家禽仍將是全球進口量最大的畜牧商品。全球對家禽產品和進口的需求正在上升。隨著可支配收入的增加，消費者轉向購買蛋白質含量高的動物性家禽產品，特別是雞肉。隨著許多發展中經濟體以及東南亞和撒哈拉以南非洲等新興市場的快速城市化，家禽產品為消費者提供了負擔得起的購買選擇，因為家禽產品的蛋白質含​​量高，並且與其他肉類產品相比更容易獲得那些很貴。為了滿足家禽產品的需求和供應，一些國家正在關注國內家禽生產。這些國家包括美國、巴西、歐盟和泰國，它們也是主要的家禽出口國。根據外交關係委員會2024年報告，2021年美國、巴西、歐盟和泰國佔全球家禽出口量的71%。產量將達到1,420 萬噸。因此，不斷成長的家禽業推動了家禽疫苗市場的成長。

歐洲家禽疫苗市場概況

在德國，家禽疾病的爆發正在顯著增加。例如，德國在 2020 年 11 月至 2021 年 5 月期間經歷了有史以來最大規模的高致病性禽流感疫情。圈養鳥類養殖場；以及1000多種野生鳥類。此外，在德國等國家，接種新城疫疫苗是一項重要的控制措施，因為該病毒在自由放養的鳥類中很常見。德國免疫常設獸醫委員會 (StIKo Vet) 建議按照目前疫苗的產品特性摘要 (SPC)，每六週透過飲用水或噴霧使用減毒活疫苗對雞隻進行重新接種。此外，艾美耳球蟲疫苗接種是蛋雞（無論是籠養還是放養的蛋雞）的重要做法，以預防和控制艾美耳球蟲病爆發的可能性。在飼養蛋雞品種和混合遺傳雛雞的「雄性兄弟雛雞」期間。因此，所有這些因素都促進了德國家禽疫苗市場的成長。

歐洲家禽疫苗市場收入及 2031 年預測（百萬美元）

歐洲家禽疫苗市場區隔

歐洲家禽疫苗市場按類型、技術、劑型、疾病、給藥途徑、最終用戶和國家分類。

根據類型，歐洲家禽疫苗市場分為肉雞疫苗和蛋雞疫苗。 2023 年，肉雞細分市場將佔據更大的市場佔有率。

從技術上來看，歐洲家禽疫苗市場分為減毒活疫苗、去活化疫苗和重組疫苗。減毒活疫苗細分市場在 2023 年佔據最大的市場。

依劑型分類，歐洲家禽疫苗市場分為液體疫苗、冷凍乾燥疫苗和粉狀/粉狀疫苗。 2023 年，液體疫苗領域佔據最大的市場。

根據疾病，歐洲家禽疫苗市場分為禽流感、傳染性支氣管炎、馬立克氏症、禽沙門氏菌病、傳染性法氏囊病（IBD）、新城疫等。 2023 年，禽流感細分市場佔最大市場。

從給藥途徑來看，歐洲家禽疫苗市場分為飲用水（D/W）、肌肉（I/M）、皮下（I/S）等。 2023 年，飲用水 (D/W) 領域佔據最大的市場佔有率。

根據最終用戶，歐洲家禽疫苗市場分為家禽養殖場和孵化場、獸醫院以及家禽疫苗接種中心和診所。 2023 年，家禽養殖場和孵化場領域佔據最大的市場。

依國家分類，歐洲家禽疫苗市場分為德國、西班牙、法國、英國、義大利和歐洲其他地區。 2023年，德國在歐洲家禽疫苗市場佔有率中佔據主導地位。

勃林格殷格翰國際有限公司、Zoetis Inc、BIOVAC、Phibro Animal Health Corp、Dechra Pharmaceuticals PLC、Elanco Animal Health Inc、Merck KGaA、Ceva 和 Vaccinova AB。是歐洲家禽疫苗市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

第 4 章：歐洲家禽疫苗市場 - 主要市場動態

  • 市場促進因素
    • 家禽疾病盛行率上升
    • 不斷發展的家禽業
  • 市場限制
    • 疫苗接種失敗和處理不當
  • 市場機會
    • 政府對大規模疫苗接種活動和創新計畫的支持
  • 未來趨勢
    • 載體疫苗和聯合疫苗的進展
  • 促進因素和限制的影響：

第 5 章：歐洲家禽疫苗市場分析

  • 2021-2031年家禽疫苗市場收入

第 6 章：歐洲家禽疫苗市場分析 - 按類型

  • 概述
  • 肉雞
  • 層

第 7 章：歐洲家禽疫苗市場分析 - 按技術

  • 概述
  • 減毒活疫苗
  • 去活化疫苗
  • 重組疫苗

第 8 章：歐洲家禽疫苗市場分析 - 按劑型

  • 概述
  • 液體疫苗
  • 凍乾疫苗
  • 粉塵/粉狀疫苗

第 9 章：歐洲家禽疫苗市場分析 - 按疾病

  • 概述
  • 禽流感
  • 禽沙門氏菌病
  • 馬立克氏症
  • 傳染性支氣管炎 (IB)
  • 傳染性法氏囊病 (IBD)
  • 新城疫
  • 其他

第 10 章：歐洲家禽疫苗市場分析 - 按給藥途徑

  • 概述
  • 飲用水（乾/乾）
  • 肌肉注射 (I/M)
  • 皮下注射（S/C）
  • 其他

第 11 章：歐洲家禽疫苗市場分析 - 按最終用戶

  • 概述
  • 家禽養殖場
  • 獸醫院
  • 家禽疫苗接種中心和診所

第 12 章：歐洲家禽疫苗市場 - 國家分析

  • 歐洲市場概況
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 歐洲其他地區

第 13 章：產業格局

  • 概述
  • 家禽疫苗市場的成長策略
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 14 章：公司簡介

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Vaccinova AB

第 15 章：附錄

Product Code: BMIRE00025385

The Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is expected to reach US$ 635.01 million by 2031; it is estimated to record a CAGR of 8.9% from 2023 to 2031.

Growing Poultry Industry Drives Europe Poultry Vaccines Market

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Europe Poultry Vaccines Market Overview

In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of "male brother chicks" of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.

Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Europe Poultry Vaccines Market Segmentation

The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Europe Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. Europe Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Europe Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Avian Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers & Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Poultry Vaccines Market - Country Analysis

  • 12.1 Europe Market Overview
    • 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 12.1.1.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Overview
        • 12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
        • 12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Overview
        • 12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Dechra Pharmaceuticals PLC
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Elanco Animal Health Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ceva
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Vaccinova AB
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Poultry Vaccines Market Segmentation
  • Table 2. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 7. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 13. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 19. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 22. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 23. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 24. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 25. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 26. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 28. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 29. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 30. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 31. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 32. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 34. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 35. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 36. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 37. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 38. Organic Developments Done by Companies
  • Table 39. Inorganic Developments Done by Companies
  • Table 40. Glossary of Terms, Poultry Vaccines Market

List Of Figures

  • Figure 1. Europe Poultry Vaccines Market Segmentation, by Country
  • Figure 2. Poultry Vaccines Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
  • Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
  • Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Europe: Poultry Vaccine Market - Revenue by Key Countries Revenue 2023 (US$ Million)
  • Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 35. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 37. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 39. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 40. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 41. Growth Strategies in the Poultry Vaccines Market